$HALB plans to test the ability of the antibody in
Post# of 8462
(Total Views: 85)
Posted On: 12/23/2020 1:00:57 PM
$HALB plans to test the ability of the antibody in blocking the infection of cells and replication of the COVID-19 virus in additional studies. This would demonstrate its potential therapeutic value in preventing damage to vital organs. The company believes that this could be an important potential therapeutic tool targeting COVID-19, either alone or in combination with other monoclonal antibody compounds, such as the treatment that was successfully administered to President Trump. https://finance.yahoo.com/news/halberd-corp-r...00488.html
(0)
(0)Scroll down for more posts ▼